Peptides
Peptides are short chains of amino acid linked by peptide bonds, typically defined as containing between 2 and 50 residues, distinguishing them from larger polypeptides and proteins.
Peptides are short chains of amino acid linked by peptide bonds, typically defined as containing between 2 and 50 residues, distinguishing them from larger polypeptides and proteins. As fundamental biological molecules, peptides participate in virtually every physiological process: they function as hormones, neurotransmitters, Signaling molecules, antimicrobial agents, and structural components. Their relatively small size compared to full proteins confers key pharmacological advantages, including improved tissue penetration, lower immunogenicity, and the capacity to engage challenging molecular targets such as protein–protein interaction interfaces that are inaccessible to small-molecule drugs. Peptides are biosynthesized through ribosomal translation or non-ribosomal enzymatic pathways, and can also be generated through the hydrolysis of larger proteins by proteases, a process central to both digestion and the production of bioactive food-derived peptides.
From a therapeutic standpoint, peptides occupy a privileged position at the interface of small molecules and biologics. Their modular amino acid sequences can be rationally engineered to confer high specificity for receptor binding, enzyme inhibition, or immune modulation. Advances in solid-phase peptide synthesis, recombinant expression, and, more recently, artificial intelligence-guided design have dramatically expanded the accessible sequence and structural space for therapeutic peptide discovery. These attributes have made peptides central targets and tools across dermatology, oncology, nanomedicine, and food science.
Where the papers sit
9 papers from the last 6 months study peptides directly · updated from PubMed 11 Oct 2026
Study type 0 clinical trials · 5 human data · 4 preclinical
Themes no clear themes · 1 paradigm shift · 1 new direction
Those 9 do not share a common subject.
-
Peptide sequence, structure, and chemical modification recur across antiviral, enzyme-inhibitory, antimicrobial, and protein-interaction studies. Computational design is paired with experimental validation for Factor Xa, p53-COP1, TCR-pMHC, and antimicrobial targets. Other work addresses peptide synthesis, ACE inhibition, virus thermostability, and temperature-responsive protein morphology. The topics share peptide-focused investigation but show no single biological direction.
Peptide function depends on engineered conformation and higher-order organization, not sequence alone
The synthetic elastin-like polypeptide constructs fused to amyloidogenic peptides and the ultrashort antimicrobial peptide WKR-cyl independently show that primary sequence is not sufficient to determine peptide performance: in the first system, peptide charge, hydrophilicity, polymer length, and environmental conditions generated distinct coacervate, micellar, and vesicular structures, while in the second, backbone amide cyclization restored activity lost through sequence minimization by stabilizing membrane-active conformations. The implication is that peptide design must treat conformation and supramolecular organization as functional variables rather than merely optimizing residue sequences 42734274Sep 42091006May.
Peptide backbones serve as programmable substrates for chemical protein synthesis
The silver(I)-mediated amide-to-ester transformation of unprotected peptides assigns peptides a role as chemically addressable scaffolds whose backbone amides can be selectively activated and converted into salicylaldehyde esters in aqueous conditions. This is distinct from using peptides as therapeutic agents, biological effectors, vaccine stabilizers, or self-assembling materials, and extends peptide work into programmable manipulation of the peptide or protein backbone itself 42814821Sep.
Papers
The 9 papers from the last 6 months that study peptides directly, newest first, by theme and by study type. Study types come from PubMed publication types and MeSH headings.
By theme
No clear themes (9)
- A dual-functional antiviral and anticancer peptide to target intricate host-pathogen interacting proteins of human papillomavirus associated with head and neck cancer. PloS one · 9 Oct 2026 PMID 42853814
- Silver(I)-mediated amide-to-ester transformation on unprotected peptides for protein chemical synthesis and engineering. Science advances · 30 Sept 2026 PMID 42814821
- Temperature-Triggered Nanoscale Morphological Transitions in a Synthetic Intrinsically Disordered Protein. Biomacromolecules · 14 Sept 2026 PMID 42734274
- Polypeptide Sequence Effects on Virus Thermostability in Complex Coacervate Formulations. Biomacromolecules · 14 Sept 2026 PMID 42734273
- Discovery and mechanistic benchmarking of ACE inhibitory Di- and tripeptides. Bioorganic chemistry · 29 Aug 2026 PMID 42667758
- Predicting specificity of TCR-pMHC interactions using machine-learning and biophysical models. Cell systems · 13 Aug 2026 PMID 42594866
- Computational design and evaluation of Factor Xa inhibitory peptides derived from the Tamarind Kunitz inhibitor reactive loop. Biochemical and biophysical research communications · 22 Jul 2026 PMID 42485797
- Computational design and experimental validation of peptide inhibitors targeting the p53-COP1 interaction to suppress p53 ubiquitination. Bioorganic chemistry · 3 Jul 2026 PMID 42398393
- Performance optimization of ultrashort antimicrobial peptides through backbone amide cyclization. European journal of medicinal chemistry · 6 May 2026 PMID 42091006
By study type
Human data, design not indexed (5)
- A dual-functional antiviral and anticancer peptide to target intricate host-pathogen interacting proteins of human papillomavirus associated with head and neck cancer. PloS one · 9 Oct 2026 PMID 42853814
- Discovery and mechanistic benchmarking of ACE inhibitory Di- and tripeptides. Bioorganic chemistry · 29 Aug 2026 PMID 42667758
- Predicting specificity of TCR-pMHC interactions using machine-learning and biophysical models. Cell systems · 13 Aug 2026 PMID 42594866
- Computational design and evaluation of Factor Xa inhibitory peptides derived from the Tamarind Kunitz inhibitor reactive loop. Biochemical and biophysical research communications · 22 Jul 2026 PMID 42485797
- Computational design and experimental validation of peptide inhibitors targeting the p53-COP1 interaction to suppress p53 ubiquitination. Bioorganic chemistry · 3 Jul 2026 PMID 42398393
Preclinical: animal, cell and lab studies (4)
- Silver(I)-mediated amide-to-ester transformation on unprotected peptides for protein chemical synthesis and engineering. Science advances · 30 Sept 2026 PMID 42814821
- Temperature-Triggered Nanoscale Morphological Transitions in a Synthetic Intrinsically Disordered Protein. Biomacromolecules · 14 Sept 2026 PMID 42734274
- Polypeptide Sequence Effects on Virus Thermostability in Complex Coacervate Formulations. Biomacromolecules · 14 Sept 2026 PMID 42734273
- Performance optimization of ultrashort antimicrobial peptides through backbone amide cyclization. European journal of medicinal chemistry · 6 May 2026 PMID 42091006
Written from 9 PubMed abstracts, each one listed by PMID above. Published: 2026-06-15. Last written: 2026-07-29 by GPT. Drafted by language models from published abstracts; not medical advice.